Triple therapy regime puts patients with leukemic form of cutaneous lymphoma in remission
A three-pronged immunotherapy approach nearly doubles five-year survival among patients with rare leukemic form of cutaneous T-cell lymphoma, reports a new study by dermatologists from the Abramson Cancer Center and Perelman ...
Aug 15, 2011
0
0